Research peptide · LY3298176
CoA included · >99% purity
Illustrative image; appearance and packaging may vary. 10 unlabelled vials, labelled only on the kit packaging. The selected strength applies.
No reviews yet. Be the first to share your experience.
Research Use Only (RUO)
Tier I · Synthesis QC
Tier I · Synthesis QC
In-house · per step
RP-HPLC, MS confirmation, sequence verification in cleanroom.
Tier II · In-process
Tier II · In-process
Batch · final
Identity, purity, and assay before release.
Tier III · Third-party lab
Tier III · Third-party lab
External · independent
HPLC, ICP-MS, and microbiology by accredited lab.
953
satisfied
99.41%
Avg. purity 2026
4.8 ★
Store rating
Tirzepatide is a synthetic peptide described in research as a dual GIP and GLP-1 receptor agonist. This identifies the molecular research context of the material.
Each box contains 10 unlabelled vials at the selected strength: 10 mg per vial equals 100 mg per box, 15 mg equals 150 mg, 20 mg 200 mg, 30 mg 300 mg, 60 mg 600 mg, and 90 mg 900 mg. Product identification appears only on the outer kit packaging.
The labelled single vial in the product image is illustrative. The selected variant and outer kit packaging determine product identification.
The cited primary paper describes LY3298176 as a dual GIP and GLP-1 receptor agonist and reports molecular pharmacology in research models. It does not establish any claim about the offered lot. PubMed: Primary source.
Further products for catalog context: Survodutide. For research use only, not for human or animal use.
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.41% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
10, 15, 20, 30, 60 and 90 mg per vial.
Ten identical vials: 100, 150, 200, 300, 600 or 900 mg total, according to the selected strength.
No. Product identification appears only on the outer kit packaging.
The product image shows an illustrative kit containing ten unlabelled vials. Product identification appears on the outer kit packaging. The same image may be used for different strengths; the selected variant determines the contents.
5-Amino-1MQ 10 mg
AHK-Cu 100 mg
BAC Water 10 ml
BPC-157 5 mg
Cagrilintide 5 mg
CJC-1295 (Mod GRF 1-29) 10 mg
CJC-1295 No DAC + Ipamorelin
DSIP 10 mg
